Table 1.
Patient Characteristics | Total (N) | Readmission | Non-Readmission | p-Value | |||
---|---|---|---|---|---|---|---|
N | % | N | % | ||||
Total | 7590 | 328 | 4.3 | 7262 | 95.7 | - | |
Sex | Male | 3095 | 170 | 5.5 | 2925 | 94.5 | <0.0001 ** |
Female | 4495 | 158 | 3.5 | 4337 | 96.5 | ||
Age | 0–19 | 431 | 10 | 2.3 | 421 | 97.7 | <0.0001 ** |
20–39 | 2629 | 70 | 2.7 | 2559 | 97.3 | ||
40–64 | 3165 | 151 | 4.8 | 3014 | 95.2 | ||
≥65 | 1365 | 97 | 7.1 | 1268 | 92.9 | ||
Healthcare Coverage | Health insurance | 6961 | 231 | 3.3 | 6730 | 96.7 | <0.0001 ** |
Medical aid | 629 | 97 | 15.4 | 532 | 84.6 | ||
Provider region | Daegu | 2696 | 79 | 2.9 | 2617 | 97.1 | <0.0001 ** |
Gyeongbuk | 1421 | 146 | 10.3 | 1275 | 89.7 | ||
Others | 3473 | 103 | 3.0 | 3370 | 97.0 | ||
Cancer | No | 7308 | 312 | 4.3 | 6996 | 95.7 | 0.2551 |
Yes | 282 | 16 | 5.7 | 266 | 94.3 | ||
COPD | No | 7031 | 296 | 4.2 | 6735 | 95.8 | 0.0901 |
Yes | 559 | 32 | 5.7 | 527 | 94.3 | ||
Ischemic heart disease | No | 7440 | 321 | 4.3 | 7119 | 95.7 | 0.8337 |
Yes | 150 | 7 | 4.7 | 143 | 95.3 | ||
Hypertension | No | 6627 | 255 | 3.8 | 6372 | 96.2 | <0.0001 ** |
Yes | 963 | 73 | 7.6 | 890 | 92.4 | ||
Diabetes | No | 6986 | 282 | 4.0 | 6704 | 96.0 | <0.0001 ** |
Yes | 604 | 46 | 7.6 | 558 | 92.4 | ||
Heart failure † | No | 7543 | 325 | 4.3 | 7218 | 95.7 | 0.4565 |
Yes | 47 | 3 | 6.4 | 44 | 93.6 | ||
Chronic kidney disease † | No | 7548 | 324 | 4.3 | 7224 | 95.7 | 0.1063 |
Yes | 42 | 4 | 9.5 | 38 | 90.5 | ||
Stroke | No | 7427 | 317 | 4.3 | 7110 | 95.7 | 0.1234 |
Yes | 163 | 11 | 6.7 | 152 | 93.3 | ||
Asthma | No | 7395 | 318 | 4.3 | 7077 | 95.7 | 0.5746 |
Yes | 195 | 10 | 5.1 | 185 | 94.9 | ||
Dementia | No | 7357 | 304 | 4.1 | 7053 | 95.9 | <0.0001 ** |
Yes | 233 | 24 | 10.3 | 209 | 89.7 | ||
Parkinson’s disease † | No | 7544 | 322 | 4.3 | 7222 | 95.7 | 0.0135 * |
Yes | 46 | 6 | 13.0 | 40 | 87.0 | ||
Liver cirrhosis | No | 7238 | 317 | 4.4 | 6921 | 95.6 | 0.2583 |
Yes | 352 | 11 | 3.1 | 341 | 96.9 | ||
Number of underlying diseases | 0 | 4949 | 157 | 3.2 | 4792 | 96.8 | <0.0001 ** |
≥1 | 2641 | 171 | 6.5 | 2470 | 93.5 | ||
CCI Score | 0 | 7500 | 301 | 4.0 | 7199 | 96.0 | <0.0001 ** |
1 | 75 | 22 | 29.3 | 53 | 70.7 | ||
≥2 | 15 | 5 | 33.3 | 10 | 66.7 | ||
Lopinavir/ritonavir use | No | 4976 | 181 | 3.6 | 4795 | 96.4 | <0.0001 ** |
Yes | 2614 | 147 | 5.6 | 2467 | 94.4 | ||
HCQ use | No | 5599 | 269 | 4.8 | 5330 | 95.2 | 0.0005 |
Yes | 1991 | 59 | 3.0 | 1932 | 97.0 | ||
Chest X-ray | No | 2172 | 45 | 2.1 | 2127 | 97.9 | <0.0001 ** |
Yes | 5418 | 283 | 5.2 | 5135 | 94.8 | ||
Chest CT | No | 5219 | 177 | 3.4 | 5042 | 96.6 | <0.0001 ** |
Yes | 2699 | 151 | 5.6 | 2548 | 94.4 | ||
ICU admission | No | 6794 | 290 | 4.3 | 6504 | 95.7 | 0.5070 |
Yes | 796 | 38 | 4.8 | 758 | 95.2 | ||
Length of stay in first admission, days ‡ | 17.0 (10.0–24.0) |
9.0 (1.0–18.0) |
17.0 (10.0–24.0) |
<0.0001 ** |
Abbreviations: COPD, chronic obstructive pulmonary disease; CCI Score, Charlson Comorbidity Index Score; HCQ, hydroxychloroquine; CT, computed tomography; ICU, intensive care unit. * p-value < 0.05, ** p-value < 0.01, † Fisher’s exact test, ‡ Wilcoxon test, Length of stay in first admission is the median value (interquartile range).